Elanco Animal Health Incorporated (ELAN) vs Teva Pharmaceutical Industries Ltd. (TEVA)
- Elanco Animal Health Incorporated ELAN 23.55 +0.04%
- Teva Pharmaceutical Industries Ltd. TEVA 41.52 +1.00%
Elanco Animal Health Incorporated and Teva Pharmaceutical Industries Ltd. are both Drug Manufacturers Specialty & Generic companies. Teva Pharmaceutical Industries Ltd. is the larger, with a market value of $47.9B against $11.8B — 4.1× the size. Elanco Animal Health Incorporated has negative trailing earnings, so its P/E is not meaningful; Teva Pharmaceutical Industries Ltd. trades at 65.9×. Elanco Animal Health Incorporated grew revenue faster over the last twelve months: 12.0% against 4.13%. Teva Pharmaceutical Industries Ltd. has the higher net margin (4.08% vs −3.96%) and the higher return on invested capital (4.58% vs 0.51%). Across the 20 metrics below, Elanco Animal Health Incorporated leads on 11 and Teva Pharmaceutical Industries Ltd. on 9.
Valuation
Profitability
| Metric | ELAN | TEVA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 55.36% | 52.46% | 53.94% |
| Operating margin | 1.61% | 8.77% | 0.00% |
| Net margin | (3.96%) | 4.08% | 0.00% |
| Free cash flow margin | 7.55% | 8.09% | 0.00% |
| Return on equity | (2.98%) | 9.69% | (0.40%) |
| Return on assets | (1.46%) | 1.77% | (3.32%) |
| Return on invested capital | 0.51% | 4.58% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack